Formulation study of a patch containing propranolol by design of experiments.
Francesco Cilurzo1, Paola Minghetti, Chiara G M Gennari
1Department of Pharmaceutical Sciences, Università degli Studi di Milano , Milan , Italy.
This study developed a transdermal propranolol (PR) patch, finding that matrix thickness and PR content are key factors for drug diffusion. The optimized patch ensures non-irritating, constant PR delivery for 48 hours.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Dermatology
Background:
- Transdermal drug delivery offers advantages over oral administration for certain medications.
- Propranolol (PR), a beta-blocker, has potential for transdermal delivery to manage various conditions.
- Optimizing transdermal patch formulations is crucial for effective and safe drug delivery.
Purpose of the Study:
- To assess the feasibility of developing a transdermal patch for propranolol (PR) delivery.
- To identify critical formulation parameters influencing PR permeation through human skin.
- To develop a non-irritating transdermal PR patch with consistent drug release.
Main Methods:
- A quality by design approach utilizing a 2(4) full factorial design for patch development.
- Selection and evaluation of skin penetration enhancers (SPEs) for PR.
- In vitro permeation studies using Franz diffusion cells with human epidermis.
- Skin irritation assessment via the Draize test.
Main Results:
- N-methyl pyrrolidone (NMP) was identified as the most effective SPE.
- Matrix thickness and PR content significantly influenced PR flux (p<0.0957 and p<0.0004, respectively).
- Optimal formulation achieved a PR flux of 12.7 μg/cm²/h, with an estimated patch surface area of 100-120 cm².
Conclusions:
- A transdermal patch containing (S)-propranolol was successfully prepared.
- The optimized patch formulation, featuring a 50 μm methacrylic matrix with 8% (S)-PR and 15% NMP, demonstrated a flux of 13.3 μg/cm²/h.
- This formulation is non-irritating and suitable for ensuring consistent PR permeation over 48 hours, confirming the viability of transdermal PR administration.
Related Concept Videos
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Methods of Medium Optimization
Modified-Release Drug Delivery Systems: Influencing Factors
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Study Design in Statistics
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...

